WO2024092347A1 - Dispositifs de culture cellulaire - Google Patents

Dispositifs de culture cellulaire Download PDF

Info

Publication number
WO2024092347A1
WO2024092347A1 PCT/CA2023/051446 CA2023051446W WO2024092347A1 WO 2024092347 A1 WO2024092347 A1 WO 2024092347A1 CA 2023051446 W CA2023051446 W CA 2023051446W WO 2024092347 A1 WO2024092347 A1 WO 2024092347A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
cell culture
culture device
channel
chip component
Prior art date
Application number
PCT/CA2023/051446
Other languages
English (en)
Inventor
Etienne Laurent
Samuel Bourdon
Thomas GERVAIS
Dina DORRIGIV
Rodin CHERMAT
Amelie ST-GEORGES-ROBILLARD
Elena REFET-MOLLOF
Gabriel PAGE
Original Assignee
Val-Chum, Limited Partnership
Polyvalor, Limited Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Val-Chum, Limited Partnership, Polyvalor, Limited Partnership filed Critical Val-Chum, Limited Partnership
Publication of WO2024092347A1 publication Critical patent/WO2024092347A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/24—Gas permeable parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/12—Well or multiwell plates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/38—Caps; Covers; Plugs; Pouring means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/08—Chemical, biochemical or biological means, e.g. plasma jet, co-culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture

Definitions

  • the present technology generally relates to cell culture devices, suitable for, but not limited to, microfluidic cell culture.
  • 3D culture model systems for simulating human physiology. These systems are also referred to as complex in vitro systems. Compared to conventional in vitro 2D cell culture techniques, 3D culture models provide a more physiologically realistic simulated environment for culturing and testing living cells in a laboratory context.
  • 3D culture models comprise an artificially created environment that permits cells to grow in three dimensions, as compared to a two dimensional environment such as a petri dish.
  • 3D culture models essentially comprise a cell culture device in which is cultured cells.
  • 3D culture models typically comprise scaffold-based methods using hydrogels for example, as well as scaffold-free approaches using freely floating aggregates referred to as spheroids.
  • 3D culture models typically (i) use, or are derived from, human cells instead of immortalized cell lines or animal cells, (ii) enable the 3D growth of cells, sometimes recreating the cellular architecture of organs, (iii) allow the perfusion of nutrients or biological fluids to the cells, and (iv) reproduce specific physiological functions in order to assess the efficacy or the toxicology of a therapeutic. [0005] Even though existing 3D culture models have certain benefits over conventional 2D in vitro techniques, limitations still remain. To this end, there is an interest in developing improved methods and systems for 3D cell culture.
  • Embodiments of the present technology have been developed based on developers’ appreciation of at least one technical problem associated with the prior art solutions.
  • the cells to be cultured (also referred to herein as “cell model”) comprise monoculture or co-culture spheroids. These spheroids are simple three-dimensional cell aggregates usually used in high-throughput systems for drug discovery or even for personalized treatment.
  • the cell model comprises organoids.
  • the organoids are 3D microtissues grown from isolated cells to recreate the arrangement of a target tissue or organ.
  • the organoids require the use of a substrate such as matrigelTM as an extracellular matrix to support the cells to grow into 3D mini-organs.
  • both these existing cell model types require prior growth of the cells into a 3D architecture.
  • the 3D architecture however lacks the native tumor microenvironment and original cell-cell interactions of a patient's tumor. This intact microenvironment is crucial to assess the effect of anticancer drugs that target it and to maximize patient-specific predictability.
  • tissue explanted from a patient are used for the cell culture.
  • the tissue may comprise explanted “intact” tumor tissues that preserve their native tumor microenvironment.
  • patient-derived explanted tissue are also referred to herein as patient-derived explants (PDE) and it is believed that 3D cell culture of such PDEs can provide a more accurate physiological replication compared to 3D culture models that use spheroids or organoids.
  • PDEs typically have a low cell viability ex vivo (3 days in average) limiting their uses.
  • the low cell viability of the PDEs may in part be due to the cell culture devices which are conventionally used with PDES, which are microfluidic devices (also known as lab-on-chips or organ-on-chips).
  • PDES which are microfluidic devices
  • Conventional microfluidic devices comprise a plurality of wells for housing the PDEs, and which wells are fed by cell culture fluid through channels.
  • One or more pumps can control the fluid flow rate through the channels.
  • the microfluidic devices are sealed other than a fluid inlet and a fluid outlet for the fluid supply and removal from the channels.
  • the microfluidic devices are typically made of polydimethylsyloxane (PDMS) which Developers have noted are susceptible to absorbing small hydrophobic molecules, such as the drug compounds being tested as well fluorescent markers of treatment response. Therefore, use of PDMS in a microfluidic device can result in inaccurate dosing of the drug compounds being tested, inaccurate dose-response interpretations, cross-contamination, and higher background fluorescence.
  • PDMS polydimethylsyloxane
  • microfluidic devices made of PDMS are challenging and expensive to mass-produce using established techniques like injection molding and extrusion, which may limit the commercial usefulness of microfluidic platforms made fully of PDMS.
  • PDEs are a preferred cell model
  • the size of PDE that is typically required for avoiding hypoxia i.e. sub-milimeter
  • standard processes for transferring tissues into paraffin for histopathological evaluation as standard paraffin embedding processes are designed for macroscopic tissues.
  • the cell culture device provides an improvement over conventional cell culture devices as cell viability in the cell culture device during cell culture is increased.
  • the cell culture device comprises different components that can be attached together, including a component with recesses and/or channels for receiving the cell models and having a removable base.
  • the removeable base may be made of a porous material permitting air diffusion therethrough for improved oxygen access to the cell models during the culture, thereby improving viability of the cultured cell models.
  • a cell culture device comprising: a chip component having: a top face and a bottom face, at least one channel formed in the chip component, the at least one channel being open at the top face, and having a base spaced from the bottom face; at least one well portion extending from the base of the at least one channel to the bottom face of the chip component, the at least one well portion being open at the bottom face of the chip component and at the base of the at least one channel; and a membrane component configured to be positioned on the bottom face of the chip component to close the open well portion, the membrane component having at least one porous portion which is aligned with the open well portion when the membrane component and the chip component are assembled together, the at least one porous portion of the membrane component being permeable to gas and impermeable to liquid.
  • the cell culture device further comprises a top cover component configured to be positioned on the top face of the chip component to substantially cover the open channel at the top face.
  • the top cover may be configured to seal the open channel at the top face.
  • the top cover component includes at least one opening that can fluidly communicate with the at least one channel when the top cover component is assembled with the chip component.
  • the cell culture device further comprises a bottom cover component configured to be positioned beneath the membrane component, the bottom cover component having at least one opening, which when the at least one opening is aligned with the porous portion of the membrane component and the open well portion of the chip component, permits gaseous communication to the at least one channel through the bottom cover component.
  • the at least one opening in the bottom cover component has a width which is wider than a width of the at least one channel in the chip component.
  • the cell culture device has an assembled configuration in which the top cover component and the bottom cover component sandwich the chip component and the membrane component therebetween.
  • the cell culture device further comprises a spacing member for spacing the membrane component from a support surface on which the cell culture device is to be supported.
  • the spacing member is a retaining member for securing together the membrane component and the chip component, and which retaining member extends outwardly from the membrane component and away from the chip component.
  • the spacing member is connected to the bottom cover.
  • the retaining member comprises a bolt, nail or a screw extending through the membrane component and optionally the chip component.
  • the cell culture device further comprises a retaining member for securing together one or more of the membrane component, the chip component, the top cover component and the bottom cover component.
  • the retaining member comprises one or more of: nuts and bolts, magnetic components, clips and straps.
  • the at least one channel comprises an inlet and an outlet.
  • one or more of the chip component, the top cover component, the bottom cover component, and the membrane component are not made of poly dimethylsiloxane (PDMS).
  • the membrane component has a surface which is functionalized.
  • one or both of the top cover component and the bottom cover component is made from a rigid polymer.
  • the top cover component is transparent or semi-transparent.
  • one or both of the top face and the bottom face of the chip component is oxygen plasma treated.
  • the membrane component is attached to the chip component.
  • a width of the well portion is less than a width of the at least one channel.
  • the at least one channel comprises a plurality of well portions spaced from one another along the at least one channel.
  • the plurality of well portions are spaced from one another such that they can be received on a standard histology slide.
  • the cell culture device further comprises a tissue model in the well portion when the chip component and the membrane component are assembled together.
  • the cell culture device further comprises culture medium in the well portion when the chip component and the membrane component are assembled together.
  • the at least one channel comprises a plurality of channels separated from one another.
  • a cell culture device comprising: a chip component having a top face, a bottom face, at least one channel formed in the chip component, the at least one channel being open at the top face, and having a base spaced from the bottom face; and at least one well portion extending from the base of the at least one channel to the bottom face of the chip component, the at least one well portion being open at the bottom face of the chip component and at the base of the at least one channel; and a membrane component configured to be positioned on the bottom face of the chip component to close the open well portion, the membrane component having at least one porous portion which is aligned with the open well portion when the membrane component and the chip component are assembled together; a top cover component configured to be positioned on the chip component to substantially cover the open channel at the top face of the chip component; a bottom cover component configured to be positioned beneath the membrane component, the bottom cover component having openings, wherein when the cell culture device is assembled, the top cover component and the bottom cover component sandwich the chip component and the
  • the bottom cover component has at least one opening, which when the at least one opening is aligned with the porous portion of the membrane component and the open well portion of the chip component, permits gaseous communication to the at least one channel through the bottom cover component.
  • a cell culture device for cell culture comprising: a chip component comprising: a plate having a plate top face and a plate bottom face, and at least one channel formed in the plate, the at least one channel having side walls defined within the plate and extending between the plate top face and the plate bottom face, the channel having an open channel top face and an open channel bottom face; a top cover component configured to be positioned on the plate top face to substantially cover the open channel top face of the at least one channel; a membrane component configured to be positioned on the plate bottom face to close the open channel bottom face of the at least one channel, the membrane component being permeable to gas and impermeable to liquid; a bottom cover component configured to be positioned beneath the membrane component, the bottom cover component having openings for permitting gaseous communication to the at least one channel through the membrane component, wherein when the cell culture device is assembled, the top cover component and the bottom cover component sandwich the chip component and the membrane component.
  • the openings in the bottom cover component have a width which is wider than a width of the at least one channel at the plate bottom face.
  • the cell culture device further comprises clamping members for removably clamping together the top cover component and the bottom cover component.
  • the clamping members comprise one or more of: nuts and bolts, magnetic components, and clips.
  • the top cover component includes one or both of an inlet and an outlet for fluidly communication with the at least one channel of the chip component when assembled.
  • one or more of the chip component, the top cover component, the bottom cover component, and the membrane component are not made of poly dimethylsiloxane (PDMS).
  • the membrane component has a surface which is functionalized.
  • one or both of the top cover component and the bottom cover component is made from a rigid polymer.
  • the top cover component is transparent or semi-transparent.
  • one or both of the top face and the bottom face of the chip component is oxygen plasma treated.
  • the membrane component is attached to the chip component.
  • the at least one channel includes a well portion, the well portion comprising a portion along the at least one channel in which a width of the at least one channel at the channel bottom face is narrower than a width of the at least one channel at the channel top face.
  • the at least one channel comprises a plurality of well portions spaced from one another along the at least one channel.
  • the components are assembled together and the well portion includes a sample of tissue positioned therein.
  • the plurality of well portions are spaced from one another such that they can be received on a standard histology slide.
  • the chip component, the top and bottom cover components and the membrane component are assembled together and further comprises culture medium in the at least one channel.
  • the at least one channel comprises a plurality of channels separated from one another.
  • a cell culture device for cell culture comprising: a chip component comprising at least one channel having an open channel top face and an open channel bottom face; a top cover component configured to be positioned on the chip component to substantially cover the open channel top face of the at least one channel; a membrane component configured to be positioned on the chip component to cover the open channel bottom face of the at least one channel; a bottom cover component configured to be positioned beneath the membrane component, the bottom cover component having openings, wherein when the cell culture device is assembled, the top cover component and the bottom cover component sandwich the chip component and the membrane component therebetween.
  • kits for a cell culture device comprising: at least one a chip component comprising at least one channel having an open channel top face and an open channel bottom face; at least one top cover component configured to be positioned on the chip component to cover the open channel top face of the at least one channel; at least one membrane component configured to be positioned on the chip component to close the open channel bottom face of the at least one channel; at least one bottom cover component configured to be positioned beneath the membrane component, the bottom cover component having openings.
  • the cell models have improved oxygen access during cell culture. As the cell models, in use, will rest on or near the base, a diffusion distance between the cell models and the ambient air is minimized.
  • the cell culture device may be provided as a kit of parts comprising different bases with different gaseous diffusion properties, and/or different chip components with different size/shape of recesses and/or channels. This can provide flexibility to a user of the cell culture device by permitting the user to build a cell culture device having desired properties appropriate to a given need, thereby allowing the user to control the cell culture conditions.
  • the modular configuration of the cell culture device permits ease of manufacture.
  • the modular configuration of the cell culture device provides versatility as the membrane component may be configured to have different properties to the chip component, such as gas permeability, and chemical functionalization.
  • the modular configuration of the cell culture device may also permit ease of post-culture processing of the cell model.
  • the cell culture device is configured such that the cell model can be embedded in paraffin for subsequent investigation by histopathology.
  • the paraffin embedding of the cell model can be performed whilst the cell culture device is in the assembled configuration, and the paraffin embedded cell model can be removed for subsequent histopathology by removing the membrane component. This can enable an entire exposed face of the paraffin embedded cell model to be exposed to the histopathological solutions, thereby maximising the post-culture testing capability.
  • the recesses and/or channels are sized for microfluidic flow. Due to the small volume of the channels, a required volume of cell culture fluid is also decreased as well as drugs and metabolites added to the cell culture fluid.
  • the cell culture device may be optically transparent allowing for optical imaging to be done directly through its top surface without disturbing the samples trapped in the wells.
  • Implementations of the present technology each have at least one of the above- mentioned object and/or aspects, but do not necessarily have all of them. It should be understood that some aspects of the present technology that have resulted from attempting to attain the above- mentioned object may not satisfy this object and/or may satisfy other objects not specifically recited herein.
  • FIG. 1 illustrates an assembled side view of a cell culture device for cell culture having a chip component, top and bottom cover components and a membrane component, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 2 illustrates an exploded isometric view of the cell culture device of FIG. 1, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 3 illustrates an exploded side view of the cell culture device of FIG. 1, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 4 illustrates an isometric view of the cell culture device of FIG. 1 with the top and bottom cover components made transparent in order to see channels on the chip component more clearly, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 5 illustrates an assembled top view of the cell culture device of FIG. 1 in which the top cover component is transparent, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 6 illustrates a cross-sectional view of the cell culture device of FIG. 5 through the line A- A, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 7 illustrates a zoomed-in view of the circled portion of the cell culture device of FIG. 6, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 8 illustrates an isometric view of the cell culture device of FIG. 1 depicting modular inlet members, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 9A illustrates an isometric view of the chip component of the cell culture device of FIG. 1, in accordance with various non-limiting embodiments of the present disclosure
  • FIG. 9B illustrates a zoomed-in view of a portion of the chip component of FIG. 9A.
  • FIG. 10 illustrates levels of oxygen in the cell culture device of FIG. 1 versus time (h) for different membrane component porosities, along with the biological Michaelis-Menten constant for oxygen (Km) and hypoxia threshold, in accordance with various non-limiting embodiments of the present disclosure.
  • a cell culture device which can be used for 3D cell culture of cell models.
  • the cell culture device may be used to house the cell models whilst exposing them to various stimuli (e.g. drugs added to the culture fluid such as chemotherapy drugs or external treatments such as radiation applied to the cell culture device).
  • the cell models suitable for culture in the cell culture device are not particularly limited.
  • the cell models comprise patient-derived explants (PDEs) such as, but not limited to, explanted tissue pieces.
  • PDEs patient-derived explants
  • the PDEs comprises pieces of explanted tissue cut into disk-like samples having a diameter of about 380 micron and a thickness of about 300 micron.
  • the cell models comprise explanted tissue pieces which are roughly spherical with diameters between about 300 microns and about 700 microns.
  • the cell models comprise explanted tissue pieces which are about 1 mm wide.
  • Embodiments of the present cell culture device may also be used with isolated cells, or cells within a tissue matrix such as spheroids and organoids.
  • the cell culture device can be used to expose the cell models to various treatments and assess cell reaction thereto.
  • Embodiments of the cell culture device can be used to assess treatment efficacy for a patient by exposing the patient’s cells to the treatment in the cell culture device before the treatment is applied to the patient.
  • Embodiments of the cell culture device provide a certain level of breathability to the cell models housed therein which may improve their viability whilst permitting liquid retention therein.
  • a cell culture device 100 which is modular and comprises components that can be laid one on top of each other and attached together in a sandwich-like layered configuration.
  • the components comprise a chip component 102 with channels 110 formed therein.
  • Each channel 110 has well portions 134 spaced apart from each other along the channel 110.
  • Each well portion 134 is a recess within the chip component 102 extending from a base 111 of the channel 110 downwardly to a bottom face 108 of the chip component 102.
  • Each well portion 134 is open at the bottom face 108 of the chip component 102, as well as at the base 111 of the channel 110.
  • Each well portion 134 is configured to house the cell model 146 when the cell culture device 100 is assembled.
  • the cell culture device 100 also has a membrane component 118 configured to be positioned on the bottom face 108 of the chip component 102 and to cover the well portions 134 at the bottom face 108 of the chip component 102 when the chip component 102 and the membrane component 118 are assembled together.
  • the cell culture device 100 also comprises top and bottom covers 116, 120 that sandwich the chip component 102 with the membrane component 118 when assembled.
  • the well portions 134 at the bottom face 108 of the chip component 102 are fluidly sealed enabling retention therein of the cell model and culture fluid.
  • One or more retention members, such as the clamping members 124 and 126 may be provided to hold together the top and bottom cover components 116, 120 with the chip component 102 and the membrane component 118 sandwiched therebetween.
  • the cell culture device 100 may include additional components not listed herein.
  • the cell culture device 100 may omit one or more of the components listed above, such as the top cover component 116. The components will each be described in further detail below.
  • the chip component 102 is plate-like and has a top face 106 and the bottom face 108. In certain embodiments, the top and bottom faces 106, 108 are parallel to one another.
  • channels 110 formed in the chip component 102 of the illustrated embodiment. In other embodiments, there may be provided any number of channels 110, such as a single channel.
  • the channels 110 may be implemented as those described in “Microdissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy”, Lab Chip, published on Dec. 02, 2015, the contents of which are hereby incorporated by reference.
  • Each channel 110 has side walls 112 and the base 111.
  • the base extends generally parallel to the top and bottom faces 106, 108, and is spaced from both the top and bottom faces 106, 108.
  • the side walls 112 extend generally transversely from the base 111 of each channel 110, although other relative configurations are within the scope of the present technology. For example, an angle of the side walls 112 may be more than or less than 90 degrees relative to the base 111.
  • Each channel 110 is open at the top face 106 of the chip component 102, and closed at the base 111 other than the open well portions 134.
  • the channels 110 of the chip component 102 are open-faced channels or slots and are generally closed at the base 111 other than recesses formed in the base 111 which are the well portions 134.
  • the chip component 102 is a microfluidic chip component meaning that the channels are sized and shaped for microfluidic flow.
  • the cell culture device 100 may have uses which are not microfluidic.
  • Each channel 110 has an inlet 130 and an outlet 132 for fluid flow therethrough.
  • channels 110 as illustrated are distinct channels which are separated from each other.
  • the plurality of channels 110 may be fluidly connected instead of fluidly separate as herein illustrated.
  • Each channel 110 has a sinusoidal configuration, although other shapes are also possible
  • each channel 110 is provided with eight well portions 134, although in other embodiments, there may be more or less well portions 134 provided per channel 110. It will be appreciated that providing a plurality of well portions 134 per channel permits multiple sample testing with the same channel 110 conditions.
  • each well portion 134 has a width 125 of about 600 microns and a height of about 500 microns. The width 125 of a given well portion 134 may be narrower than a width 127 of the given channel 110 in which it is formed (as shown in FIG. 7).
  • well portions 134 in the cell culture device 100 may have the same or different dimensions.
  • the well portions 134 are illustrated as having a cuboid configuration but in other embodiments, the well portions 134 may have any other shape such as cylindrical, conical, etc.
  • each well portion 134 may be designed as a function of the size of the cell model 146 to be housed in the well portion 134. This is the case particularly when the cell models are micro-dissected tissues.
  • each well portion 134 may be selected so as to provide a desired trapping stability of the cell model 146, a desired cell viability of the cell model 146 within a desired culture time (e.g. no loss of cell proliferation activity and no significant cell death in a 15 day period), a desired shear stress generated when changing the culture medium and a desired metabolism of the cell models 146.
  • the cell models 146 may have a diameter of between about 300 microns and about 700 microns. Accordingly, each well portion 134 may have size and shape sufficient to house the largest cell model 146 (assuming all the well portions 134 have the same size), for example a cross-sectional footprint of about 800 microns x about 800 microns, and a height of about 700 microns.
  • the given channel 110 must have a width sufficient to allow the largest cell model 146 to pass through to the well portion 134, for example a width of at least 800 microns. .
  • the cell models 146 may have a diameter of up to about 1 mm. Accordingly, the cell culture device 100 has well portions 134 sized to house the cell models 146, and channels 110 of sufficient size to permit the cell models 146 to pass therethrough.
  • the cell culture device 100 when assembled, at least one of the plurality of well portions 134 may include the cell model 146 positioned therein. Additionally, the cell culture device 100, when assembled, may comprise a culture medium in the well portion 134 or the channel 110.
  • the channels 110 may be implemented as described in “Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy”, Lab Chip, Jan 21, 2016, the contents of which are hereby incorporated by reference.
  • the top cover component 116 is configured to be positioned on the top face 106 of the chip component 102 to substantially close the channels 110 at the top face 106.
  • the top cover component 116 may include openings 128 such that, when the cell culture device 100 is assembled, the openings 128 may fluidly communicate with respective channels 110 of the chip component 102.
  • a respective opening 128 may align with a respective channel inlet 130 or a channel outlet 132 when the cell culture device 100 is assembled.
  • the top cover component 116 may cover the channels 110 except for a portion of the channels that may remain uncovered because of the openings 128, and/or other openings defined therein for receiving the retaining members, such as the clamping members 124, 126. In other embodiments in which there are no openings 128 provided in the top cover component 116, the top cover component 116 may function to fluidly seal the channels 110 at the top face 106.
  • the top cover component 116 may be transparent or semi-transparent allowing for optical imaging to be done directly through the top cover component 116 without disturbing the trapped cell models.
  • the chip component 102 and/ or the top cover component 116 may be configured such that the cell models 146 can be positioned into the channels 110 by injection.
  • an inlet member 131 may be provided for insertion into the opening 128 of the top cover 116.
  • the cell models 146 and/or fluids may be injected into each channel 110 through the inlet member 131 and the inlet 130.
  • the outlet 132 may be used to remove the cell models 146 and/or the fluid.
  • the inlet 130 may have a diameter of about 3 mm, and the outlet 132 may have a diameter of about 2 mm.
  • the top cover component 116 may include channels that line up with the channels 110 of the chip component 102. In yet other embodiments, further channels may be provided on one or both of the top cover component 116 and the bottom cover component 120 to thereby form one or more networks of channels throughout the cell culture device 100.
  • the membrane component 118 is configured to be positioned on the bottom face 108 of the chip component 102 to close the bottom face 108 at the well portions 134.
  • the membrane component 118 thus functions as a base of the well portions 134 when the cell culture device 100 is assembled.
  • the membrane component 118 may be made of a different material or have a different configuration than the chip component 120.
  • the membrane component 118 may be permeable to gas, such as air, and impermeable to liquids thereby permitting gaseous diffusion to the well portions 134 whilst retaining liquid within the well portions 134 and the channels 110.
  • at least a portion of the membrane component 118 may be porous.
  • the membrane component 118 may be porous throughout.
  • the membrane component 118 may be porous only in areas that line up with the well portions 134 of the chip component 102 when the cell culture device 100 is assembled.
  • the membrane component 118 is sized and shaped to cover all the well portions 134. In this respect, the membrane component 118 may be smaller than the chip component 102 as long as the well portions 134 are covered by it. In certain embodiments, the membrane component 118 is the same size and shape as the chip component 102.
  • a porosity of the membrane component 118 may be selected depending on the intended application for which the cell culture device 100 is to be used.
  • the membrane component 118 with specific attributes may be selected and assembled in the cell culture device 100.
  • the membrane component 118 with a relatively lower porosity may be selected to create hypoxic culture conditions for cell models 146
  • a membrane component 118 with a relatively higher porosity may be selected to create hyperoxic culture conditions for cell models 146.
  • the material of the membrane component 118 may include one or more of polytetrafluoroethylene (PTFE) polymer, expanded-PTFE (e-PTFE) polymer, polyethylene-PTFE (Pe-PTFE) polymer, Fluorinated ethylene propylene (FEP) polymer, Polyvinylidene fluoride (PVDF) polymer, Polydimethylsiloxane (PDMS) polymer, Polyethylene terephthalate (PET) polymer, Polylactic acid (PLA) polymer, polymethylpentene (PMP) polymer, poly(l-trimethylsilyl-l-propyne) (PTMSP) polymer, poly methylated polymer such as polymethylated poly(diphenylacetylene), and/ or any other suitable polymer that may achieve sufficient gas permeability through any suitable mechanism.
  • PTFE polytetrafluoroethylene
  • e-PTFE expanded-PTFE
  • Pe-PTFE polyethylene-PTFE
  • FEP Fluorinated
  • the membrane component 118 may have hydrophobic properties for minimizing or preventing fluid leakage out of the bottom of the cell culture device 100 through the well portions 134 when the cell culture device 100 is assembled.
  • the membrane component 118 may be attached to the chip component 102, such as by one or more of: adhesive, heat lamination. [0120] In certain other non-limiting embodiments, the membrane component 118 may be separate from the chip component 102 and connectable thereto, such as by clamping between the top and bottom cover components 116, 120.
  • the membrane component 118 may be functionalized with functional groups such as one or more of: proteins, biomolecules or a chemically defined component having CFx, NHx, Si, OH, CO2 groups, without being limited thereto.
  • the membrane component 118 may have controlled pore sizes, from no porosity to very high porosity, to control gas exchanges across it.
  • a pore size of the membrane component 118 may be selected according to a desired gas exchange.
  • the membrane component 118 may have pores with different pore sizes.
  • the membrane component 118 may have sensors to detect specific analytics within the cell culture device 100.
  • the bottom cover component 120 is configured to be positioned adjacent the membrane component 118.
  • the bottom cover component 120 has openings 122 for permitting gaseous communication to the well portions 134 through the membrane component 118.
  • the bottom cover component 120 is sized and shaped to cover the membrane component 118 and optionally the chip component 102.
  • the openings 122 are aligned with the well portions 134 when the cell culture device 100 is assembled.
  • the bottom cover component 120 is the same size and shape as one or both of the chip component 102 and the membrane component 118.
  • a given opening 122 in the bottom cover component 120 may have a width 123 which is wider than the width 125 of a given well portion.
  • the width 123 of the openings 122 in the bottom cover component 120 may be wider than the width 127 of the channel 110. Having the width 123 of the openings 122 wider than the width 125 of the given well portion 134 and/or the width 127 of the channel 110, may provide an improved flow of oxygen to the cell model 146 in the well portion 134.
  • the openings 122 may have any appropriate cross-sectional shape, such as circular, square, etc.
  • a thickness of the bottom cover component 120 is also not limited, and any suitable thickness may be selected to achieve the desired gas diffusion.
  • one or more of the chip component 102, the top cover component 116 and the bottom cover component 120 may be made from a rigid polymer.
  • materials that can be used to form one or more of the chip component 102, and the top and/or bottom cover components 116, 120 include polycarbonates (PC), polystyrenes (PS), polyethylene (PE), cyclic olefin co-polymers (COG), cyclic olefin polymers (COP).
  • one or more of the chip component 102, the top cover component 116, the membrane component 118, and the bottom cover component 120 may be made of a material which is not PDMS.
  • the advantage of one or more of the top cover component 116, the membrane component 118, and the bottom cover component 120 not being made of PDMS is that any detrimental effect by PDMS is avoided. In other words, it may be advantageous to avoid or minimize components that will contact the cell models 146 or the cell culture fluid being made of PDMS.
  • the top cover component 116 and the bottom cover component 120 sandwich the chip component 102 and the membrane component 118 therebetween.
  • Retention members may be provided to retain the cell culture device 100 in the assembled state.
  • the retention members are removeable and permit disassembly of the cell culture device 100.
  • the retention members comprise the clamping members 124 and 126 which are nuts and bolts. Corresponding openings are provided in each of the components of the cell culture device 100 through which the bolt can be threaded.
  • any suitable retention members may be provided, for example, magnets, clips, bands, straps, or the like.
  • the retention members such as the clamping members 124, 126 may have one or more of the following functions: i) to keep all the components of the cell culture device 100 together with sufficient pressure to avoid leaking of the fluids, ii) to be removable in order to permit the user to remove and replace components of the device during an experiment, and iii) to ensure proper alignment of the components.
  • FIG. 7 illustrates a cross-sectional view through the cell culture device 100 including the channels 110 and the well portions 134, as well as the associated interfaces at the top and bottom faces 106, 108 of the chip component 102. More particularly, as illustrated in FIG. 7, in certain non-limiting embodiments, an interface between the top cover component 116 and the chip component 102 when the cell culture device 100 is assembled comprises a fluid seal therebetween. An interface between the bottom face 108 of the chip component 102 and the membrane component 118 when the cell culture device 100 is assembled may also include a fluid seal. Alternatively, or in addition, the bottom cover component 120 and the membrane component 118 may also comprise a fluid seal.
  • the fluid seal is achieved through a clamping pressure from the retaining members.
  • the fluid seal may be obtained or enhanced by an additional sealing means such as one or more of adhesive, plasma treatment (e.g., oxygen plasma treatment), and/or with sufficient surface pressure (e.g., o-ring surface seal) or any other suitable sealing agent.
  • one or both of the top face 106 and the bottom face 108 of the chip component 102 may be oxygen plasma treated.
  • the top cover component 116, the chip component 102, the membrane component 118 and the bottom cover component 120 may be sealed in a manner permitting disassembly of the individual components by the user as required.
  • control of oxygen available to the cell models 146 allows for control of hypoxia within the cell models 146. As such, a precise control of the oxygen is useful for simulating certain tumor microenvironment conditions.
  • the availability of oxygen to the cell models 146 can be controlled by the membrane component 118 and the openings 122 of the bottom cover component 120 (as shown in FIGs. 3 and 7). Selection of appropriate gaseous diffusion properties of the membrane component 118 and/or the size and positioning of the openings 122 can modulate the oxygen availability to the cell models. Airflow can thus be provided from the bottom cover component 120 to the membrane component 118 for ensuring that the cell models 146 have sufficient oxygen access.
  • certain embodiments of the cell culture device 100 may provide improved viability of the cultured cell models 146 from the point of view of sufficient oxygen availability.
  • the cell culture device 100 may be configured to provide sufficient oxygen to the cell models 146 despite the use of gas-impermeable thermoplastic material for the chip component 102, and despite the static culture of the cell models 146 (i.e., without continuous perfusion and replenishment of the culture medium in the channels).
  • the chip component 102 may minimize a distance between the cultured cell models 146 and ambient air, thus providing sufficient oxygen for cell viability.
  • oxygen may diffuse through the culture medium before getting to the cell models 146, as the cell models 146 may be positioned near to the membrane component 118.
  • the cell models 146 may also need to be provided with sufficient nutrients, e.g., glucose, that can be provided with the culture medium in which the cell models 146 may be submerged.
  • sufficient nutrients e.g., glucose
  • a replenishment of the nutrient may be required, and a critical size of the cell model 146 may be considered.
  • the cell culture device 100 may provide a mechanism that allows the replenishment of nutrients.
  • the cell culture device 100 may allow for sufficient nutrient access by having a volume of culture medium big enough to provide the amount of nutrients required by the cell models 146 over a period of, for example, 24 hours. To replenish the nutrients the user may only have to change the culture medium every day or two simplifying the process compared to conventional microfluidic platforms requiring a setup of pumps to ensure the perfusion of the medium culture.
  • FIG. 10 illustrates levels of oxygen in an embodiment of the cell culture device 100 versus time (h) for different porosities of the membrane component 118, along with the biological Michaelis-Menten constant for oxygen (km) and hypoxia threshold, in accordance with various non-limiting embodiments of the present disclosure.
  • the cell model 146 used were cut pieces of explant tissue having a size of about 380 micron diameter and 300 micron height. More particularly, FIG.
  • FIG. 10 illustrates a normalized minimum concentration of oxygen in the cell model 146 versus time for different porosities of the membrane component 118 demonstrating that i) oxygen levels are above the threshold for viability of the cell model 146 in the cell culture device 100 and ii) that oxygen levels in the cell model 146 are a function of the porosity of the membrane component 118.
  • the Michaelis-Menten constant is used to indicate the threshold under which oxygen concentration limits uptake kinetics.
  • the cell culture device 100 may provide different methods for loading the cell models 146 in the cell culture device 100.
  • the cell models 146 when the cell models 146 are cut pieces of explant tissue having a size of about 380 micron diameter and 300 micron height, the cell models 146 may be injected with a fluid at the inlet 130 of the assembled cell culture device 100 with a pipette (not illustrated).
  • a pipette By controlling the flow of the fluid with the pipette, the user may stop when the cell models 146 are over a given one of the plurality of well portions 134 and let the cell models 146 sediment.
  • the cell models 146 may be placed directly in the plurality of well portions 134 while the membrane component 118 and the bottom cover component 120 are in place and with the top cover component 116 is removed (as shown in FIG. 9).
  • the cell culture device 100 may be provided as a kit with different types of any of the components such as different versions of: the membrane component 118 (e.g. having different gaseous diffusion properties), the top cover component 116 (e.g. having different sizes of openings 128), the bottom cover component 120 (e.g. having different size openings), and the chip component 102 (e.g. having different size channels 110 and/or well portions 134) that would enable different applications.
  • the membrane component 118 e.g. having different gaseous diffusion properties
  • the top cover component 116 e.g. having different sizes of openings 128)
  • the bottom cover component 120 e.g. having different size openings
  • the chip component 102 e.g. having different size channels 110 and/or well portions 134) that would enable different applications.
  • a first type of the top cover component 116 may be used to inject a specific volume of culture medium in the well portions 134 only, then a second type of the top cover component 116 may be positioned in place to close the channel 110 and let the user perform the culture medium changes. Finally, a third type of the top cover component 116 may be used for the transfer of cell models 146 into paraffin for embedding.
  • the plurality of well portions 134 may be designed to fit in the standard dimensions of a histology cassette. Such arrangement may enable the cell culture device 100 to be compatible with the Paraffin-Embedded Lithography process. The cell culture device 100 thus facilitates the generation of histopathology endpoints, reduces the fixation time of the cell models 146 and the transfer of the cell models 146 into paraffin.
  • embodiments of the cell culture device 100 may be compatible with methods, such as those described in U.S. patent application Ser. No. US 2020/0124507, “Medium-embedded samples,” filed on October 19, 2018, the contents of which are hereby incorporated by reference.
  • the method comprises separating the top cover component 116 of the cell culture device 100 from the chip component 102, placing embedding medium in the channels 110 including the well portions 134 such that the embedding medium immerses the tissue models 146 in the well portions 134; allowing the embedding medium to form a block of embedding medium including the tissue models 146 embedded therein; and separating the chip component 102 from the block of embedding medium to obtain the medium-embedded- sample-block.
  • Placing the embedding medium in the well portions 134 may comprise filling the well portions 134 with the embedding medium, filling a given channel 110 above the well portions 134 with the embedding medium, and forming a layer of embedding medium above the well portions 134.
  • the embedding medium may be a paraffin-based composition.
  • the method before placing the embedding medium in the well portions 134, the method may comprise dehydrating the tissue models 146.
  • the embedding medium may be in a liquid state when immersing the tissue models 146, and the allowing the embedding medium to form the block of embedding medium comprises allowing a change in a state of the embedding medium from the liquid state to a solid state.
  • Placing the embedding medium in the well portions 134 may comprise immersing the chip component 102 in the embedding medium. In certain embodiments, this comprises placing the chip component 102 and the membrane component 118 (and optionally the top and bottom covers 116, 120) within an open container, the open container being deeper than a height of the chip component 102, and adding the embedding medium to fill the open container over the chip component 102 such that the chip component 102 is immersed in the embedding medium.
  • the first block is separated from the components of the cell culture device 100.
  • the first block can then be further processed to allow compatibility with standard histopathology techniques.
  • the first block is further treated by placing the first block in a mold, optionally with more paraffin, and re-melting the first block and allowing the tissue models 146 to settle at the base of the metal mold before resolidifying. This further step can achieve a flat surface of paraffin with the aligned tissue models 146 therein which can facilitate the thin section processing.
  • the chip component may be flushed with other materials for preservation such as OCT (cryopreservation), agarose, hydrogels, polyacrylamide, and collagen.
  • the cell culture device 100 may be fabricated with different fabrication techniques due to the different parts that compose the cell culture device 100.
  • the top cover component 116 and the bottom cover component 120 may consist of simple rigid plastic parts with holes and microchannels depending on the embodiment.
  • the top cover component 116 and the bottom cover component 120 may be made by laser cutting or micro milling depending on the thermoplastic used (3 mm thick polycarbonate for instance may not be compatible with laser cutting and may be micromilled with a CNC). These techniques allow rapid prototyping and are convenient for medium volume of production. For a larger production volume >10 000, the top cover component 116 and the bottom cover component 120 may be produced by injection molding, as the thermoplastics used may be injectable or may be hot embossed.
  • the chip component 102 may be fabricated by soft lithography or soft thermoplastic lithography depending on the material to be used. In certain non-limiting embodiments, hot embossing may also be employed.
  • the membrane component 118 may be cut into dimensions that cover the plurality of well portions 134. In certain non-limiting embodiments, the membrane component 118 may be placed under the chip component 102. In certain non-limiting embodiments, the membrane component 118 may be laminated to the bottom cover component 120 in order to reduce the number of parts the user may be required to assemble. In certain non-limiting embodiments, the lamination may be done by spraying a biocompatible adhesive to the bottom face 108 of the chip component 102 and adding the membrane component 118 to the bottom face 108.
  • the cell culture device 100 may be assembled.
  • the cell culture device 100 may be performed by the end user. In so doing, a manufacturing cost of the cell culture device 100 may be reduced and it may also enable the user to use different variants of the top cover component 116 and the bottom cover component 120 or the membrane components 118 based on the application and use.
  • the assembly of the cell culture device 100 may include putting the components in a sandwich formation with the following order from top to bottom: the top cover component 116, the chip component 102, the membrane component 118 and the bottom cover component 120. It is to be noted that while the components of the cell culture device 100 may be assembled without any alignment effort as the components may be designed to fit together when assembled.
  • the top face 106 may be treated with oxygen plasma to increase adherence and sealing with the top cover component 116.
  • the cell culture device 100 may be prepared for culturing.
  • the plurality of channels 110 may be treated with a plutonic F108 solution for few hours (e.g., 24 hours). Then the plutonic F108 solution may be washed out and the cell models 146 may be inserted into the cell culture device 100 with a culture medium.
  • the cell culture device 100 may be used for drug screening in the context of drug discovery by enabling the direct testing of therapeutic agents, or radiation treatments, on cell models 146 cultured in the cell culture device 100. Many assays may be designed with the cell culture device 100 and the users may control the type of treatment, treatment regimen, types of endpoints, time of endpoints, etc. [0158] It is to be noted that the cell culture device 100 may assist in performing various measurements.
  • the cell culture device 100 may be imaged as the top cover component 116 may be optically clear, culture medium may be collected after culture to be analyzed, the cell models 146 may also be collected from the cell culture device 100 and then be characterized in any suitable manner such as flow cytometry or RNA sequencing, or the like.
  • the cell culture device 100 may be used in clinical settings for the personalization of the treatment of a patient with cancer.
  • the cell models may comprise MDTs derived from a patient tumor biopsy which is loaded into to the cell culture device 100 (in the well portions) and then may be exposed to a candidate treatment to assess the patient-specific sensibility to the treatment.
  • This assay may provide predictive information regarding the patient-specific response to the treatment. This assay may provide, to a medical doctor, valuable insight to better design the patient's treatment plan.
  • This assay may also be executed before any treatment is given to a patient and may save the patient from undergoing an ineffective cancer treatment and from undesirable side effects if the ex vivo assay identifies the patient as non-responder of the treatment.
  • the patient derived MDTs may be tested ex vivo in the cell culture device 100 and may undergo a direct transfer to paraffin for subsequent histological analysis.
  • This predictive assay may serve as a companion diagnostic tool, along with an approved treatment, to help patients and doctors prescribe the right personalized treatment.
  • the cell culture device 100 may consume minimal amount of reagent due to the low volume channels 110 and thus reduces cost of experiments compared to macroscopic vessels. Additionally, the cell culture device 100 may preserve cell model ex vivo viability and proliferation activity 5x times longer (almost 15 days) than the conventional techniques, e.g., tissue slice model and Farcasf tumoroid.
  • the cell culture device 100 may increase throughput of assays using primary cell models (such as MDTs) by lOx times compared to other conventional techniques, e.g, tissue slice model.
  • primary cell models such as MDTs
  • spheroids and PDEs may not require extracellular matrix substitutes like matrigelTM for the 3D growth of the cells. This offers a cost-effective means for cultivating human-relevant cell models.
  • the dimensions of the chip component 102 may be compatible with clinical radiotherapy and small animal radiotherapy machines.
  • Some of the additional benefits of embodiments of the cell culture device 100 may include one or more of: i) capability to grow cells in a 3D architecture, ii) circumvent the need to buy specialized equipment related to microfluidics, iii) capability to do low to high throughput experiments, iv) accelerate and ease the fixation and transfer into paraffin of the PDEs or spheroids, v) reduce the quantity of reagent needed per experiment (compared to multi well plates), vi) a means to refine and reduce animal use for research, vii) reduce absorption of small hydrophobic molecules in the microfluidic system (compared with PDMS-based systems), viii) a more physiologically-relevant models (than 2D culture) to test drugs in vitro and evaluate their effect, ix) a cost-effective mean to evaluate drug effect on microtissues with their native tumor microenvironement (when PDEs of cancer tissue are used with the cell culture device 100), x) a cost-effective mean to identify sensitive or resistant in vivo models
  • the components of the cell culture device 100 may be provided as a kit.
  • the kit may include at least one chip component 102.
  • the kit may further include at least one top cover component 116 configured to be positioned on the chip component 102.
  • the kit may further include at least one membrane component 118 configured to be positioned on the chip component 102 to close the well portions 134 at the bottom face 108 of the chip component 102.
  • the kit may further include at least one bottom cover component 120 configured to be positioned beneath the membrane component 118, the bottom cover component 120 having the openings 122.
  • the kit may include instructions for use of the kits such as for assembling the components of the cell culture device 100.
  • the instructions may be printed on a packaging of the kit or may be printed on a paper and the paper is included in the kit.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Clinical Laboratory Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Dispositif de culture cellulaire comprenant : un composant de puce présentant : une face supérieure et une face inférieure, un canal constitué dans le composant de puce ouvert sur la face supérieure et présentant une base espacée de la face inférieure ; une partie de puits se déployant de la base du canal à la face inférieure du composant de puce, la partie de puits étant ouverte sur la face inférieure du composant de puce et à la base du canal ; et un composant de membrane conçu pour être positionné sur la face inférieure du composant de puce afin de fermer la partie ouverte du puits, le composant de membrane présentant une partie poreuse qui est alignée avec la partie ouverte du puits lorsque le composant de membrane et le composant de puce sont assemblés ensemble, la partie poreuse du composant de membrane étant perméable au gaz et imperméable au liquide.
PCT/CA2023/051446 2022-10-31 2023-10-31 Dispositifs de culture cellulaire WO2024092347A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263420834P 2022-10-31 2022-10-31
US63/420,834 2022-10-31

Publications (1)

Publication Number Publication Date
WO2024092347A1 true WO2024092347A1 (fr) 2024-05-10

Family

ID=90929050

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2023/051446 WO2024092347A1 (fr) 2022-10-31 2023-10-31 Dispositifs de culture cellulaire

Country Status (1)

Country Link
WO (1) WO2024092347A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130164848A1 (en) * 2010-09-08 2013-06-27 Shimadzu Corporation Cell culture container and cell culture method using the container
WO2016065470A1 (fr) * 2014-10-27 2016-05-06 The Governing Council Of The University Of Toronto Dispositif microfluidique pour dosages à base de cellules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130164848A1 (en) * 2010-09-08 2013-06-27 Shimadzu Corporation Cell culture container and cell culture method using the container
WO2016065470A1 (fr) * 2014-10-27 2016-05-06 The Governing Council Of The University Of Toronto Dispositif microfluidique pour dosages à base de cellules

Similar Documents

Publication Publication Date Title
KR101037343B1 (ko) 세포 배양 용구 및 세포 배양 방법
US11034925B2 (en) Cell culture and invasion assay method and system
US9637715B2 (en) Cell culture and invasion assay method and system
EP2920292B1 (fr) Appareil et procédés pour des mesures de tissu tridimensionnel sur la base d'un écoulement de milieu contrôlé
US8679737B2 (en) Microfluid device and method of producing diffusively built gradients
CN114887675A (zh) 用于培养和实验的整合微流控系统
EP1893742B1 (fr) Dispositif de culture de cellules et de tissus
US10744505B2 (en) Microfluidic device for in vitro 3D cell culture experimentation
WO2011014674A2 (fr) Dispositif microfluidique pour l’étude pharmacocinétique – pharmacodynamique de médicaments et ses utilisations
Lee et al. Microtechnology‐based organ systems and whole‐body models for drug screening
US9518977B2 (en) Microfluidic assay apparatus and methods of use
WO2024092347A1 (fr) Dispositifs de culture cellulaire
US20240182831A1 (en) A well insert and a device for 3d cell culture and in vitro tissue model
JP7078918B2 (ja) バイオチップ及びバイオアッセイ装置並びにバイオアッセイ方法
JP2008301758A (ja) 細胞培養装置
CN217922153U (zh) 一种可实现气溶胶和液体两维度暴露的微型芯片装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23883937

Country of ref document: EP

Kind code of ref document: A1